BioTech, Digital Health, Public Health and Telehealth

Let’s Save the Date and Make Patient Engagement Official in 2022

Society for Participatory Medicine

JANUARY 27, 2022

Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. Market forces drove acceleration in digital health, specifically telemedicine, which were sorely needed for several years. Connect with her at [link].

BioTech

BioTech Life Science Drug Development Patient Experience

Value-Based Health Care Needs All Stakeholders at the Table – Especially the Patient

Health Populi

MARCH 11, 2021

Note: I may be biased as a University of Michigan graduate of both the School of Public Health and Rackham School of Graduate Studies in Economics]. health care, patient assistance programs, Medicare Advantage plans, and the bundling of proven high-value preventive services into the Affordable Care Act.

Health Policy

Health Policy Medicare Pharmaceuticals Life Science

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

Digital Health Global

NOVEMBER 20, 2023

–(BUSINESS WIRE)–AstraZeneca today launches Evinova, set to be a leading provider of digital health solutions to better meet the needs of healthcare professionals, regulators and patients. Patient interaction is available through an easy-to-use, engaging patient app available in more than 40 countries and 80 languages.

Life Science

Life Science Digital Health Drug Development Patient Experience

Connected Health Pulse

Let’s Save the Date and Make Patient Engagement Official in 2022

Value-Based Health Care Needs All Stakeholders at the Table – Especially the Patient

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

Stay Connected